The fda makes it really hard for companies to get drugs approve that aren't in the us p manual. The only method th t they've approved is l a l and they have not adopted the synthetic version. It's going to be very difficult for pharma seutical companies to get truds approved. And meanwhile, things get even more difficult for the horseshoe crabs themselves.
The long-trailed counter-offensive to retake the Russian-occupied regional powerhouse and symbolically powerful provincial capital has begun. But Ukraine’s forces are in no hurry. Visa and Mastercard are two of the world’s most profitable companies; we look at efforts to break their iron grip on the payments market. And the blue-blooded horseshoe crabs that are needlessly bled in their millions.
For full access to print, digital and audio editions of The Economist, subscribe here www.economist.com/intelligenceoffer